Brain macrophages after brain injury leads to negative behavioral outcomes
Brain macrophages after brain injury leads to negative behavioral outcomes
批准号:
10291314
负责人:
Ying Li
金额:
$38.47万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-08-01 至 2024-07-31
关键词:
AdultAffectAnxiety DisordersApoptosisAutopsyBehaviorBehavioralBehavioral AssayBlood VesselsBrainBrain InjuriesCellsCessation of lifeChronicDataDevelopmentDiagnosticElectroencephalogramElectrophysiology (science)Emergency SituationEvolutionFlow CytometryFunctional disorderGene Expression ProfileGenetic TranscriptionHospitalizationHumanImageImmuneImmune responseInfiltrationInflammationInflammatory ResponseInjuryKnowledgeLifeMacrophage ActivationMaintenanceMediatingMediator of activation proteinMembraneMental DepressionMental disordersMessenger RNAMicrogliaModelingMolecularMood DisordersMorphologyMusNeuronsPathologicPathologyPathway interactionsPatternPeripheralPhysiologicalPhysiologyPopulationProliferatingPropertyPublic HealthRNARecoveryReporterReportingResolutionRoleSignal PathwayStructureTechniquesTherapeuticTherapeutic InterventionTransgenic OrganismsTraumatic Brain InjuryVisitbasebehavioral outcomebehavioral phenotypingcell typechemokine receptorfunctional outcomesimprovedinterdisciplinary approachmacrophagemonocytemonocyte chemoattractant protein 1 receptorneuroinflammationneuronal excitabilityneuropathologypatch clampprognostictooltranscriptome sequencingtwo-photon
中文摘要
项目摘要:
TBI是一个严重的公共卫生问题,仅在2014年就有253万次急诊、住院和
死亡发生在美国。在人类死后研究中,小胶质细胞/单核细胞源性
巨噬细胞(MDM),慢性神经炎症的关键介质被检测到,即使在几年后,
关于TBI小胶质细胞-常驻免疫细胞-维持脆弱的神经元微环境,
通过监视和增殖,当需要时,在损伤或病理条件下,
条件在TBI损伤CNS后,单核细胞进入脑并分化成MDM,并成为
在形态上与活化的小胶质细胞无法区分。据报道,小胶质细胞/MDM
创伤性脑损伤(TBI)病理学。然而,目前尚不清楚单核细胞/MDM是如何被激活的。
在亚细胞(RNA)、细胞和网络水平上与小胶质细胞功能不同。我们的核心假设
TBI后,小胶质细胞和MDM对慢性炎症反应的贡献不同,神经元
兴奋性和行为缺陷因此,本研究的目的是深入了解
i)MDM/小胶质细胞中的mRNA变化如何影响损伤进展,ii)它们如何相互作用,以及
血管,以及iii)MDM如何影响神经元活动和随后的行为结果,
到小胶质细胞这一认识可能有助于发展有效的诊断学、诊断学和
治疗学我们建议使用双转基因报告小鼠,RNA测序,慢性双光子成像
爆炸性脑外伤条件下的电生理工具是提供所需知识的首次尝试。
英文摘要
Project Summary:
TBI is a serious public health concern, and in 2014 alone 2.53 million emergency visits, hospitalizations, and
death occurred in USA. In human post-mortem studies, accumulation of microglia/monocyte-derived
macrophages (MDM), the key mediators of chronic neuroinflammation were detected, even after several years
of TBI. Microglia -the resident immune cells- maintain the delicate neuronal microenvironment under
physiological conditions through surveillance and proliferate when needed under injury or pathological
conditions. Upon injury to the CNS from TBI, monocytes enter the brain and differentiate into MDM, and become
morphologically indistinguishable from the activated microglia. Microglia/MDMs have been reported to contribute
significantly to traumatic brain injury (TBI) pathology. However, it remains unclear how monocytes/MDM are
functionally distinct from microglia at the subcellular (RNA), cellular, and network levels. Our central hypothesis
is that after TBI, microglia and MDM contribute differently to the chronic inflammatory response, neuronal
excitability, and behavioral deficits. Hence, the objective of this study is to develop an in-depth understanding
of: i) how mRNA changes in MDMs/microglia affect injury progression, ii) how they interact with each other and
blood vessels, and iii) how MDMs influence neuronal activity and subsequent behavioral outcomes, compared
to resident microglia. This understanding may help the development of effective diagnostics, prognostics and
therapeutics. Our proposal to use double transgenic reporter mice, RNA sequencing, chronic-two photon imaging
and electrophysiological tools in blast TBI condition is the very first attempt to provide the needed knowledge.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Aptamer Based Technology for Molecular Analysis of Leukemia
-
批准号:8036000
-
项目类别:
-
资助金额:$29.49万
-
财政年份:2008
-
负责人:Ying Li
-
依托单位:
Aptamer Based Technology for Molecular Analysis of Leukemia
-
批准号:7768465
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2008
-
负责人:Ying Li
-
依托单位:
Aptamer Based Technology for Molecular Analysis of Leukemia
-
批准号:7466553
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2008
-
负责人:Ying Li
-
依托单位:
Aptamer Based Technology for Molecular Analysis of Leukemia
-
批准号:7618634
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2008
-
负责人:Ying Li
-
依托单位:
Aptamer Based Technology for Molecular Analysis of Leukemia
-
批准号:8223244
-
项目类别:
-
资助金额:$29.49万
-
财政年份:2008
-
负责人:Ying Li
-
依托单位:
海外基金